The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Microarray gene expression study of the RESPECT trial for the identification of prognostic and predictive markers.
Mauro Delorenzi
No relevant relationships to disclose
Sarah Gerster
No relevant relationships to disclose
Josep Tabernero
Consultant or Advisory Role - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; ImClone Systems; Lilly; Merck KGaA
Honoraria - Amgen; Merck KGaA; Novartis; Roche; Sanofi
Claus-Henning Köhne
No relevant relationships to disclose
Peter J. O'Dwyer
No relevant relationships to disclose
Alberto F. Sobrero
Consultant or Advisory Role - Amgen; Bayer; Roche; Sanofi
Honoraria - Amgen; Bayer; Roche; Sanofi
Eric Van Cutsem
Research Funding - Bayer
Rocio Garcia-Carbonero
Consultant or Advisory Role - Bayer (I)
Ramon Salazar
No relevant relationships to disclose
Fernando Rivera
Research Funding - Bayer
Leslie M. Samuel
Research Funding - Onyx
Vanessa Alice Potter
No relevant relationships to disclose
Yu-Lin Chang
Employment or Leadership Position - Onyx
Stock Ownership - Onyx
Nathalie Andrienne Lokker
Employment or Leadership Position - Onyx
Stock Ownership - Onyx
Sabine Tejpar
Research Funding - Onyx